{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:01:15Z","timestamp":1753887675822,"version":"3.41.2"},"reference-count":38,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0103-2021","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T12:17:19Z","timestamp":1627042639000},"source":"Crossref","is-referenced-by-count":2,"title":["Assessment of factors associated with potential drug-drug interactions in patients with tuberculosis and HIV\/AIDS"],"prefix":"10.1590","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-1083","authenticated-orcid":false,"given":"Nat\u00e1lia Helena de","family":"Resende","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-4472","authenticated-orcid":false,"given":"Silvana Sp\u00edndola de","family":"Miranda","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-0659","authenticated-orcid":false,"given":"Maria das Gra\u00e7as Braga","family":"Ceccato","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-7338","authenticated-orcid":false,"given":"Adriano Max Moreira","family":"Reis","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-6288","authenticated-orcid":false,"given":"Jo\u00e3o Paulo Amaral","family":"Haddad","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3597-8063","authenticated-orcid":false,"given":"Dirce In\u00eas da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil; Funda\u00e7\u00e3o Hospitalar do Estado de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-6352","authenticated-orcid":false,"given":"W\u00e2nia da Silva","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2021]]},"reference":[{"year":"2016","series-title":"Global Tuberculosis Report 2016","key":"ref1"},{"year":"2010","series-title":"Priority research questions for tuberculosis\/human immunodeficiency virus (TB\/HIV) in HIV-prevalent and resource-limited settings","key":"ref2"},{"edition":"2\u00aa ed","year":"2019","series-title":"Manual de Recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil","key":"ref3"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/infdis\/jiv009","article-title":"Drug metabolism and Drug Interactions: Potential Application to Antituberculosis Drugs","volume":"211","author":"Sahasrabudhe V","year":"2015","journal-title":"J Infect Dis"},{"year":"2013","series-title":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Adultos vivendo com HIV\/aids","key":"ref5"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/QAD.0000000000001401","article-title":"The challenge of polypharmacy in an aging population and implication for future antiretroviral therapy development","volume":"31","author":"Smith JM","year":"2017","journal-title":"AIDS"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next Therapeutic Challenge in HIV: Polypharmacy","volume":"30","author":"Edelman JE","year":"2013","journal-title":"Drugs Aging"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/09540121.2015.1109583","article-title":"Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH","volume":"27","author":"Moore HN","year":"2015","journal-title":"Aids Care"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/pharmaceutics3040745","article-title":"Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and Role of Therapeutic Drug Monitoring for Management","volume":"3","author":"Rathbun CR","year":"2011","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome","volume":"196","author":"McIlleron H","year":"2007","journal-title":"J Infect Dis"},{"year":"2019","series-title":"DRUG-REAX\u00ae System (electronic version)","key":"ref11"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","article-title":"Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis","volume":"26","author":"Jyrkka J","year":"2009","journal-title":"Drugs Aging"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1518-8345.1193.2832","article-title":"Potential drug interactions in patients given antiretroviral therapy","volume":"24","author":"Santos WM","year":"2016","journal-title":"Rev Lat Am Enfermagem"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/17425255.2014.993606","article-title":"Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center","volume":"11","author":"Farhoud M","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/hiv.12205","article-title":"Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach","volume":"16","author":"Iniesta-Naval\u00f3n C","year":"2014","journal-title":"HIV med"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1060028016685115","article-title":"Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients","volume":"51","author":"Jakeman B","year":"2017","journal-title":"Ann Pharmacoter"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0956462415574632","article-title":"Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort","volume":"27","author":"Lewis JM","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2710.2003.00541.x","article-title":"Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care","volume":"29","author":"De Maat MM","year":"2004","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1592\/phco.27.10.1379","article-title":"Prevalence and Risk Factors for Clinically Significant Drug Interactions with Antiretroviral Therapy","volume":"27","author":"Miller CD","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1345\/aph.1P576","article-title":"Predictors of Clinically Significant Drug-Drug Interactions Among Patients Treated with Nonnucleoside Reverse Transcriptase Inhibitor, Protease Inhibitor, and Raltegravir Based Antiretroviral Regimens","volume":"45","author":"Patel N","year":"2011","journal-title":"Ann Pharmacoter"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/jcpt.12222","article-title":"Comparison of two databases to detect potential drug-drug interaction between prescriptions of HIV\/AIDS patients in critical care","volume":"40","author":"Ramos GV","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1592\/phco.31.5.480","article-title":"Clinically significant Drug interactions in younger and Older Human Immunodeficiency Virus-Positive Patients Receiving Antiretroviral Therapy","volume":"31","author":"Yiu P","year":"2011","journal-title":"Pharmacotherapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/TCRM.S118442","article-title":"Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast","volume":"12","author":"Abrogoua DP","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/ejhpharm-2016-001106","article-title":"Analysis of self-reported adverse reactions to efavirenz and drug interactions in a population with HIV in Mexico","volume":"25","author":"Mart\u00ednez-Salazar M F","year":"2018","journal-title":"Eur J Hosp Pharm"},{"year":"2019","series-title":"Dolutegravir para pacientes coinfectados com HIV e tuberculose","key":"ref25"},{"year":"2019","series-title":"Substitui\u00e7\u00e3o do of\u00edcio circular n\u00ba 46\/2019\/CGAHV\/DCCI\/SVS\/MS - Amplia\u00e7\u00e3o do uso de dolutegravir (DTG) 50mg 2X\/dia para paciente com coinfec\u00e7\u00e3o tuberculose e HIV em uso de rifampicina","key":"ref26"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jcph.756","article-title":"Long Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of EFV and 8-Hydroxi-EFV in Ethiopian patients","volume":"56","author":"Habtewold A","year":"2016","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.112.195701","article-title":"Dendritic spine injury induced by the 8-hydroxy metabolite of EFV","volume":"343","author":"Tovar-y-Romo LB","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"ref29","first-page":"88","article-title":"Predictors of tuberculosis treatment outcomes","volume":"38","author":"Orofino R L","year":"2012","journal-title":"J Bras Pneumol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1715163516641136","article-title":"Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management","volume":"149","author":"Tisdale JE","year":"2016","journal-title":"Can Pharm J"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/apc.2013.0076","article-title":"Counselor-based rapid HIV testing in community pharmacies","volume":"27","author":"Calderon Y","year":"2013","journal-title":"AIDS Patient Care STDs"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.2146\/ajhp070048","article-title":"Effects of pharmacists\u2019 interventions on patient outcomes in an HIV primary care clinic","volume":"64","author":"March K","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/apc.2012.0189","article-title":"Impact of HIV specialized pharmacies on adherence and persistence with antiretroviral therapy","volume":"26","author":"Murphy P","year":"2012","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"ref34","first-page":"1","article-title":"Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States","volume":"7","author":"Sax PE","year":"2012","journal-title":"PLoS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/PPA.S30244","article-title":"The impact of HIV clinical pharmacists on HIV treatment outcomes: A systematic review","volume":"6","author":"Saberi P","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"ref36","first-page":"18","article-title":"The role of the pharmacist in TB management","volume":"77","author":"Mkele G","year":"2010","journal-title":"SA Pharmaceutical Journal"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11096-008-9191-x","article-title":"Evaluation of frequently used drug interaction screening programs","volume":"30","author":"Vonbach P","year":"2008","journal-title":"Pharm World Sci"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","article-title":"Drug-drug interaction software in clinical practice: a systematic review","volume":"71","author":"Roblek T","year":"2014","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T12:17:45Z","timestamp":1627042665000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822021000100329&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":38,"alternative-id":["S0037-86822021000100329"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0103-2021","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"type":"electronic","value":"1678-9849"},{"type":"print","value":"0037-8682"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e0103-2021"}}